# Single Subject Neratinib in Bladder Cancer (NRR)

> **NCT01956253** · — · NO_LONGER_AVAILABLE · sponsor: **UNC Lineberger Comprehensive Cancer Center**

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Neratinib

## Key facts

- **NCT ID:** NCT01956253
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** 2013-07
- **Primary completion:** 2013-09
- **Final completion:** 2014-06
- **Target enrollment:** — (—)
- **Last updated:** 2017-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956253, "Single Subject Neratinib in Bladder Cancer (NRR)". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT01956253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*